Published Articles

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2902751-3

  • Global, Regional and National Burden of Colorectal Cancer, 1990-2019: A systematic examination for Global Burden of Disease 2019. Lancet Gastroenterology & Hepatology 2022 Published Online April 7, 2022. https://doi.org/10.1016/ S2468-1253(22)00044-9

https://www.thelancet.com/action/showPdf?pii=S2468-1253%2822%2900044-9

  • Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019.  Lancet Diabetes Endocrinol 2022

Published Online February 7, 2022. https://doi.org/10.1016/ S2213-8587(21)00349-1

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00349-1/fulltext

  • Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.  Lancet Public Health 2022 Published Online January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8

https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00249-8/fulltext

  • Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019.   A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. Published   online December 30, 2021. doi:10.1001/jamaoncol.2021.6987

https://jamanetwork.com/journals/jamaoncology/fullarticle/2787350

  • Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review. J Ovarian Res. 2021 Oct 9;14(1):130.  doi: 10.1186/s13048-021-00870-5

https://pubmed.ncbi.nlm.nih.gov/34627352

  • The association between muscle indicators and bone mass density and related risk factors in the diabetic elderly population: Bushehr Elderly Health (BEH) Program. J Diabetes Metab Disord. 2021 Aug 28;20(2):1439-1447.  doi:10.1007/s40200-021-00882-4

https://pubmed.ncbi.nlm.nih.gov/34900795

  • Comparison of anthro-metabolic indicators for predicting the risk ofmetabolic syndrome in the elderly population: Bushehr Elderly Health (BEH) program. Journal of Diabetes & Metabolic Disorders volume 20, pages1439–1447 (2021). DOI: 10.1007/s40200-021-00882-4

https://pubmed.ncbi.nlm.nih.gov/34900795

https://www.sciencedirect.com/science/article/abs/pii/S2405457721001285?dgcid=rss_sd_all

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459558/pdf/12958_2021_Article_831.pdf

  • The global burden of adolescent and young adult cancer in 2019: An analysis of the Global Burden of Disease Study 2019.  Lancet Oncol 2022; 23: 27–52. Published Online December 3, 2021. https://doi.org/10.1016/ S1470-2045(21)00581-7

https://www.thelancet.com/action/showPdf?pii=S1470-2045%2821%2900581-7

  • Global, regional, and national mortality among young people aged 10 to 24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.  Lancet 2021; 398: 1593–618 page 1545. DOI:https://doi.org/10.1016/S0140-6736(21)01546-4

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2901546-4

  • Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019.   Lancet HIV 2021; 8: e633–51. DOI:https://doi.org/10.1016/S2352-3018(21)00152-1

https://www.thelancet.com/action/showPdf?pii=S2352-3018%2821%2900152-1

  • Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019.   Lancet Infect Dis 2021 Published Online September 23, 2021 https://doi.org/10.1016/ S1473-3099(21)00449-7

https://www.thelancet.com/action/showPdf?pii=S1473-3099%2821%2900449-7

  • Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nature Medicine  VOL 27  October 2021  1761–1782. doi: 10.1038/s41591-021-01498-0

https://www.nature.com/articles/s41591-021-01498-0.pdf

  • Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.  Lancet Neurol 2021; 20: 795–820. https://doi.org/10.1016/ S1474-4422(21)00252-0

https://www.thelancet.com/action/showPdf?pii=S1474-4422%2821%2900252-0

  • Global, regional, and national progress toward Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet 2021. Published online August 17, 2021. https://doi.org/10.1016/S0140-6736(21)01207-1

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2901207-1

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2900516-X

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739806/pdf/41586_2020_Article_3043.pdf

https://www.thelancet.com/action/showPdf?pii=S2214-109X%2820%2930230-8

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204–22. https://doi.org/10.1016/S0140-6736(20)30925-9

https://bbibliograficas.ucc.edu.co:2152/science/article/pii/S0140673620309259?via%3Dihub

  • Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries. and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1160–203. DOI:https://doi.org/10.1016/S0140-6736(20)30977-6

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930977-6

  • Global burden of 87, risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global . Burden of Disease Study 2019. Lancet 2020; 396: 1223–49DOI:https://doi.org/10.1016/S0140-6736(20)30752-2

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30752-2/fulltext

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1250–84. https://doi.org/10.1016/ S0140-6736(20)30750-9

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930750-9

  • Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 .and 2017. Nature Medicine | VOL 26 | May 750 2020 | 750–759 .https://doi.org/10.1038/s41591-020-0807-6

https://www.nature.com/articles/s41591-020-0807-6

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116361/pdf/EMS103698.pdf

  • Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17. Lancet Glob Health 2020; 8: e1162–85. DOI:https://doi.org/10.1016/S2214-109X(20)30278-3

https://www.thelancet.com/action/showPdf?pii=S2214-109X%2820%2930278-3

https://www.ijcrr.com/uploads/2681_pdf.pdf

  • Evaluation Of The Prognostic Level Of PSA In Patients With Prostate Cancer Undergoing Orchiectomy And Drug Therapy. International Journal of Current Medical And Pharmaceutical Research, Vol. 6, Issue, 04(A), pp. 5072-5079, April, 2020. DOI: http://dx.doi.org/10.24327/23956429.ijcmpr202004868

https://journalcmpr.com/sites/default/files/issue-files/2001-A-2020.pdf

https://acta.tums.ac.ir/index.php/acta/article/view/7990

  • Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017. The Lancet. VOLUME 395, ISSUE 10239, P1779-1801, JUNE 06, 2020 https://doi.org/10.1016/S0140-6736(20)30114-8

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930114-8

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology. 2019;5(12):1749-1768. doi:10.1001/jamaoncol.2019.2996

https://jamanetwork.com/journals/jamaoncology/fullarticle/2752381

  • Patient Flow Analysis in General Hospitals: How Clinical Disciplines Affect Outpatient Wait Times. Hosp Pract Res. 2019 Dec;4(4):128-133

http://www.jhpr.ir/article_99076_1fa38b763cbfb23c70e210aac28e31e0.pdf

  • Developing a Quality Registry Network on Colorectal Cancer Care (QRN-CRC) in Iran; report of the pilot phase. NAACCR – IACR 2019 | June 9 – 13, 2019
  • Disease Free Survival for Non-Metastatic Colorectal Cancer Cases in Three Referral Hospitals in Iran; Interim Report of the CRC Quality Registry Network (QRN-CRC). NAACCR – IACR 2019 | June 9 – 13, 2019
  • Lymphovascular and Perineural Invasions Are Independently Associated with Advanced Colorectal Carcinoma. Int J Cancer Manag. 2019 November; 12(11):e95540. doi: 10.5812/ijcm.95540.

http://intjcancermanag.com/en/articles/95540.html

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494974/

  • Mapping 123 million neonatal, infant and child deaths between 2000 and 2017. NATURE VOLUME 574, pages353–358(2019). https://doi.org/10.1038/s41586-019-1545-0

https://www.nature.com/articles/s41586-019-1545-0.pdf

  • The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2019. VOLUME 4, ISSUE 12, P934-947, DECEMBER 01, 2019. https://doi.org/10.1016/S2468-1253(19)30347-4

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(19)30347-4/fulltext

  • The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2019. VOLUME 4, ISSUE 12, P913-933, DECEMBER 01, 2019https://doi.org/10.1016/S2468-1253(19)30345-0.

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(19)30345-0/fulltext

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018. Volume: 392. Issue: 10159. Pages: 1736-1788. DOI: 10.1016/S0140-6736(18)32203-7

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)32203-7.pdf

  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018 . Volume: 392. Issue: 10159. Pages: 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)32279-7.pdf

  • Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 , LANCET . NOV 10 2018. Volume: 392 .Issue: 10159. Pages: 1859-1922 . DOI: 10.1016/S0140-6736(18)32335-3

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)32335-3.pdf

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018. Volume: 392. Issue: 10159. Pages: 1923-1994. DOI: 10.1016/S0140-6736(18)32225-6

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)32225-6.pdf

  • Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018; Volume: 392. Issue: 10159. Pages: 2091-2138. DOI: 10.1016/S0140-6736(18)32281-5

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)32281-5.pdf

  • Association Between Surgical Margin Status and Local Recurrence in Iranian Patients Suffering from Colorectal Cancer,  Int J Cancer Manag. 2018 November; 11(11):e83029

http://intjcancermanag.com/en/articles/83029.html

  • Conference: 43rd ESMO Congress (ESMO) Location: Munich, GERMANY Date: OCT 19-23, 2018
    Sponsor(s): European Soc Med Oncol; Japanese Soc Med Oncol. ANNALS OF ONCOLOGY   Volume: 29   Supplement: 8   Meeting Abstract: 236P   Published: OCT 2018

https://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=1&SID=E39X8j2URPkpyYgfSqm&page=1&doc=10

  • The Accuracy of Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy in Clinically Node Positive Breast Cancer Patients: A Single Institution Experience, INTERNATIONAL JOURNAL OF CANCER MANAGEMENT. DEC 2018. Volume: 11. Issue: 12. Article Number: e83946. DOI: 10.5812/ijcm.83946

https://neoscriber.org/cdn/serve/314ad/eb367153529d2f0e0c2716ecb9837c7ae936b30a/ijcm-11-12-83946.pdf

  • Number of Lymph Nodes Assessed in Iranian Gastric Cancer patients. Basic & Clinical Cancer Research, 2018; 10(1): 12-21

 http://bccr.tums.ac.ir/index.php/bccrj/article/view/263

  • Performance Assessment of Appointment System in Managing Outpatients’ Waiting Time in a General Hospital: A Case Study.  International Journal of Hospital Research 2017, 6(4): x-x

http://ijhr.iums.ac.ir/article_90621_54e4a20182c5e1ee3f6edd5c99d727ef.pdf

  • Male Adenoid Cystic Carcinoma of Breast. International Journal of Cancer Management (IJCM). 2017 September; 10(9):e7827.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884210/

  • Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients. International Journal of Cancer Management (IJCM). 2017 April; 10(4):e6260

http://ijcancerprevention.com/en/articles/6260.html

  • Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors. Asian Pacific Journal of Cancer Prevention, Vol 17, 2016, PP:249- 254

http://www.apocpcontrol.org/page/apjcp_issues_view.php?pno=8719&gubun=p&s_search=&s_paper_vol=17&s_number33=1

  • Malignant Retroperitoneal Hemangiopericytoma: Report of a 73 Years Old Woman and Review of Literature. Thrita Vol. 2, Issue 2, Nov 2013 PP:80-3

     http://thritajournal.com/?page=article&article_id=10606

  • The Phase 2 Study of “(TOX) Preoperative Chemotherapy” Response Rate and Side Effects in  [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and  Capcitabine.  ranian Journal of Cancer Prevention, Vol. 6, No. 3, Summer 2013 PP: 133-140

      http://journals.sbmu.ac.ir/index.php/cp/article/view/4291

  • Comparison of Artificial Neural Network and Cox Regression Models in Survival Prediction of Breast Cancer Patients. Scientific Journal of Ilam University of Medical Sciences, Vol. 22, No. 2, Spring 2013 PP:120-128

 http://www.sjimu.medilam.ac.ir/browse.php?a_code=A-10-220-

  • Complete Chemotherapeutic Regression of a Non- Metastatic of Primary Pure Small Cell arcinoma

of the Prostate.  Current Urology, An international journal for new findings in urology. Vol. 6, No. 1, 2012   May 2012 PP: 43-45

http://content.karger.com/ProdukteDB/produkte.aspAktion=Ausgabe&Ausgabe=257165&ProduktNr=231997